Christina C. Chang

Commercial Road, 3181
Prahran, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Coreceptor usage of plasma and cerebrospinal fluid-derived HIV-1 subtype C variants.

Coreceptor usage of plasma and cerebrospinal fluid-derived HIV-1 subtype C variants.

Journal: Virology journal

Published: December 02, 2025

Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions.

Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions.

Journal: The Journal of antimicrobial chemotherapy

Published: June 27, 2024

PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment.

PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment.

Journal: Nature communications

Published: March 15, 2024

A Confusing Collapse: Case of an Intracranial Mass Mimicker in a Cardiac Transplant Recipient.

A Confusing Collapse: Case of an Intracranial Mass Mimicker in a Cardiac Transplant Recipient.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 17, 2024

Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.

Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.

Journal: The Lancet. Infectious diseases

Published: September 06, 2023

Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials?

Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials?

Journal: The Journal of infectious diseases

Published: June 17, 2023

Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia.

Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia.

Journal: Pathology

Published: October 16, 2022

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.

Journal: Annals of internal medicine

Published: August 08, 2022

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.

Journal: American journal of respiratory and critical care medicine

Published: May 17, 2022

Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021.

Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021.

Journal: Internal medicine journal

Published: December 22, 2021

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021.

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021.

Journal: Internal medicine journal

Published: December 22, 2021

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.

Journal: medRxiv : the preprint server for health sciences

Published: December 21, 2021

Showing 1-12 of 50

Last Updated: 09/26/2026